Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI Cash ratio

Cash ratio at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.2×-0.1×
Danaher logo
DanaherDHR
0.8×+0.5×
Repligen logo
RepligenRGEN
4.6×0.0×
ADMA Biologics logo
ADMA BiologicsADMA
1.9×+0.5×
Revvity logo
RevvityRVTY
0.7×-1.1×
TEC
Bio-TechneTECH
1.4×+0.5×

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+204%
Enterprise value$954.59M+198%
P/S4.2×+3.0×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

cash and equivalents/total current liabilities=3.9×

Based on the most recent quarter.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s cash ratio?
Maravai LifeSciences Holdings, Inc. (MRVI) reported cash ratio of 3.9× in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s cash ratio changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s cash ratio decreased by 13.7% year-over-year, from 4.5× to 3.9×.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s cash ratio?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s cash ratio has grown at a 21.7% compound annual growth rate (CAGR), from 1.8× to 4.8×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.